Medpace Holdings Inc vs Zoom Video Communications, Inc. — how do they compare? Medpace Holdings Inc trades at $532.77 (market cap $15.08B), while Zoom Video Communications, Inc. trades at $89.35 (market cap $26.66B). The key difference: Zoom Video Communications, Inc. is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Zoom Video Communications, Inc. nearer its low. Which is the better fit depends on your goals.
| MEDP | ZM | |
|---|---|---|
Market Cap | $15.08B | $26.66B |
Sector | Technology | Technology |
52-Week High | $620.59 | $111.88 |
52-Week Low | $308.88 | $69.77 |
Enterprise Value | $14.55B | $19.00B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Zoom Communications (ZM) trades at $91.04, down 0.1% on the day, with a bullish technical signal from moving averages and support at $90. The company reported Q1 2026 EPS of $1.55, beating expectations, and maintains strong profitability with a net income margin of 42.0%. Recent news highlights AI product launches and a $1 billion buyback authorization, while analyst consensus price target sits at $118.79.
The outlook for ZM is cautiously optimistic, with upside potential driven by AI integration and solid cash flow, but risks include competitive pressure from Microsoft and Google, insider selling, and fluctuating cash flow trends. Wall Street sentiment is mixed, with 39% of analysts rating it Buy amid moderate growth projections.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →